Moderate Probable

설명

Carbamazepine significantly reduces venlafaxine plasma concentrations through CYP3A4 induction, potentially reducing antidepressant efficacy.

기전

Carbamazepine induces CYP3A4 and CYP2C19, which are involved in venlafaxine metabolism, accelerating its clearance and reducing plasma levels.

임상적 중요성

Sub-therapeutic venlafaxine levels may lead to depression relapse or inadequate pain control in patients using it for neuropathic pain.

관리 방법

Monitor clinical response; venlafaxine dose increase may be required; consider an antidepressant less affected by CYP3A4 induction.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.